申请人:Anacor Pharmaceuticals, Inc.
公开号:US07816344B2
公开(公告)日:2010-10-19
This invention provides, among other things, novel oxaboroles which are monosubstituted at the 3-, 6-, or 7-position, or disubstituted at the 3-/6- or 3-/7- positions, which are useful for treating bacterial infections, pharmaceutical compositions containing such oxaboroles, as well as combinations of these oxaboroles with at least one additional therapeutically effective agent.
本发明提供了新型的氧硼烷,其在3-、6-或7-位置单取代,或在3-/6-或3-/7-位置双取代,对治疗细菌感染有用。还提供了包含这些氧硼烷的制药组合物,以及这些氧硼烷与至少一种其他治疗有效药物的组合。